BiliaryTractCancer near Hudson, FL

Care Philosophy: Dr Pimiento earned his MD degree at the Universidad Nacional de Colombia. He completed a general surgery residency at Saint Mary's Health System/Affiliated Yale University School of Medicine and a Fellowship in Surgical Research in Vascular Surgery at Yale University School of Medicine. He then completed a Fellowship in Surgical Oncology and Advanced Fellowship in Surgical Oncology Research at Moffitt Cancer Center. Dr Pimiento joined Moffitt from Mercy Health Partners/Mercy Health-St. Mary's and served as the Medical Director, Surgical Oncology at the Lacks Cancer Center. Dr Pimiento's clinical interest is in malignancies of the upper gastrointestinal tract, including esophageal, gastric, pancreatic, colorectal and liver cancers.

Care Philosophy: Dr Sean Dineen is an Assistant Member of the Department of Gastrointestinal Oncology at Moffitt Cancer Center. Dr Dineen has a particular interest in the treatment of patients with metastatic disease, including carcinomatosis. In particular, he focuses on patients that have developed peritoneal spread of disease and the application of heated intraperitoneal chemotherapy (HIPEC) in the treatment of this advanced process. Dr Dineen's research focuses on identifying how the tumor and the local environment interact to promote metastatic disease. Dr Dineen is a native of Lexington, KY. He earned his medical degree from the University of Louisville.

Care Philosophy: Alberto A Chiappori, MD currently serves as Senior Member of Oncology and Medicine for the Thoracic Oncology Program at the H Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He has been a member of the Thoracic Oncology Program at Moffitt since 2001. Dr Chiappori received his MD from the Universidad Peruana Cayetano Heredia in Lima, Peru. After graduation, he completed his residency at Southern Illinois University School of Medicine in Springfield, Illinois. He then went on to finish his fellowship and senior fellowship in medical oncology-hematology at Vanderbilt University School of Medicine in Nashville, Tennessee. Dr Chiappori has been Board Certified in Medical Oncology since 1997.

Biography: Dr. Victoria Rizk is a board-certified medical oncologist who specializes in the care and treatment of patients with breast cancer. Prior to joining Tampa General, Dr. Rizk worked as a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City, where she provided comprehensive care, support and education for patients with breast cancer. Additionally, she was an instructor in medicine at Weill Medical College of Cornell University. Dr. Rizk graduated from an accelerated, six-year B.A./M.D. program at the University of Missouri-Kansas City School of Medicine. She then completed Internal Medicine Residency at the University of South Florida Morsani College of Medicine and Hematology/Oncology Fellowship at the University of South Florida/Moffitt Cancer Center in Tampa. Skilled in clinical research, Dr. Rizk is credited with several peer-reviewed publications, abstracts and presentations. Dr. Rizk has memberships with the American Society of Clinical Oncology, the European Society for Medical Oncology, the American College of Physicians and the American Medical Association.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patients experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Care Philosophy: Dr Andrew (Andy) Brohl is a medical oncologist and physician-scientist. His clinical interest is in the care of patients with a diagnosis of sarcoma or a cutaneous (skin) malignancy, including melanoma. Dr Brohl's laboratory research focuses on the utilization of genomics and other high-throughput technologies to learn more about rare cancers and for clinically translational applications. Examples of his current projects include genomic analysis of rare cancer subtypes, identification of drug targets from -omics datatypes, application of genomics for personalized cancer therapy, and development of non-invasive molecular profiling technology.

Care Philosophy: Dr Dilling's primary clinical focus is the radiotherapeutic treatment of thoracic malignancies.Dr Dilling's research interests focus around the use of Big Data and artificial intelligence to generate novel insights into patient treatment and toxicity. To that end, he has curated a database of thousands of patients who have received radiotherapy to the lung at Moffitt (millions of data points). This data set is among the largest/most complex clinical data sets on radiotherapy patients in the world.

Care Philosophy: Dr G Daniel Grass is an Assistant Member and clinical-investigator in the Department of Radiation Oncology. Dr Grass received his MD and PhD in Molecular and Cellular Biology and Pathobiology from the Medical University of South Carolina, Medical Scientist Training Program. He completed a Radiation Oncology Residency at Moffitt Cancer Center/University of South Florida. He is focused on treating patients with genitourinary malignancies (e.g. prostate, bladder, kidney, penile, ureter, testicular) by implementing novel approaches with leading edge radiation technologies.

Biography: Dr. Craig E. Grossman is a radiation oncologist at Tampa General Hospital (TGH). Before coming to TGH, Dr. Grossman accumulated an extensive range of professional and academic experiences. Most recently, he served as an Assistant Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center in New York, and and trained radiation therapists and dosimetrists as a Clinical Assistant Professor in the School of Health Technology and Management at Stony Brook University in Stony Brook, New York.Dr. Grossman has shared his expertise on a variety of radiation oncology topics through lectures at international meetings, hospitals and universities, and in the community. He has also contributed to the development of innovative radiation treatments, as well as published national guidelines related to genitourinary cancer (i.e. prostate, bladder, testicular) and gynecology cancer (i.e. endometrial, cervix, vagina, vulva) management. He is an expert in the treatment of prostate cancer with brachytherapy and stereotactic body radiotherapy (SBRT) among other treatment modalities, as well as treating women with various radiation techniques for their gynecologic cancer. Dr. Grossman has both clinical and research interests in sexual medicine, minimizing radiation-related side effects, and new technologies to treat cancer to improve cure rates.

Care Philosophy: Dr Jonathan Zager is the Chief Academic Officer and a surgical oncologist and Senior Member in the Departments of Cutaneous Oncology and Sarcoma at Moffitt Cancer Center. Dr Zager is the Director of Regional Therapies at Moffitt's Donald A Adam Comprehensive Melanoma Research Center. Dr Zager is the Chair of the Department of Oncologic Sciences and a Professor of Surgery at the University of South Florida, Morsani School of Medicine. Dr Zager's research and clinical interests include the regional therapy treatment of cutaneous melanoma and non-melanoma skin cancers, soft tissue sarcomas. Dr Zager is internationally known for the management and study of locoregionally recurrent melanoma, non-melanoma skin cancer and soft tissue sarcoma.

Care Philosophy: Dr Ricardo Gonzalez is a surgical oncologist and Chair of the Sarcoma Department at Moffitt Cancer Center. He also serves as a member of the Cutaneous Program at Moffitt Cancer Center. He is an associate professor at the University Of South Florida College Of Medicine's Department of Oncologic Sciences and Department of Surgery. Dr Gonzalez' research and clinical interests include outcomes analyses and management of patients with soft tissue sarcomas, retroperitoneal sarcomas, desmoid tumors, gastrointestinal stromal tumors (GIST) and head and neck melanoma.